Drug Trial Radar · NCT03774836
Tramadol Versus Placebo and Morphine in the Management of Post-Operative Pain Abdominoplasty
Last checked: Nov 20, 2026Latest source record: May 9, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
360
Planned (sponsor's estimate)
Start
Dec 14, 2018
Primary completion
May 30, 2019
Study completion Jun 30, 2019
Sponsor
- Lead sponsor
- Avenue Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Dec 13, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is evaluating the analgesic efficacy of intravenous (IV) tramadol (AVE-901) compared to placebo in the management of postoperative pain following abdominal surgery.
Conditions
- Pain Management
Interventions
TramadolDrug
IV Tramadol 50 mg, given at Hours 0, 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, and 44
MorphineDrug
Morphine 4 mg, given at Hours 0, 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, and 44
PlaceboOther
Placebo, given at Hours 0, 2, 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, and 44
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Sum of Pain Intensity Differences through 24 hoursTime frame: 24 hours post dose
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Lotus Clinical Research
Pasadena, California
Hermann Drive Research
Houston, Texas
Endeavor Clinical Trials
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.